Jenny J Zhang

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

P. Thompson, A. O'donnell, W. Boersma, 2014, The Lancet. Respiratory medicine.

Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease

G. Chertow, Shao-Lee Lin, Joseph H. Lin, 2014, Nephron.

Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)

P. Thompson, A. O'donnell, W. Boersma, 2013 .

Efficacy, Safety and Tolerability of E5501 (AKR501) In a 6-Month Extension Study In Subjects with Chronic Immune Thrombocytopenia (ITP).

J. Bussel, D. Kuter, Jenny J Zhang, 2010 .

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial on the Efficacy, Safety and Tolerability of E5501 (AKR501) In Subjects with Chronic Immune Thrombocytopenia (ITP)

J. Bussel, D. Kuter, Jenny J Zhang, 2010 .

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.

H. Collard, F. Martinez, G. Raghu, 2017, The Lancet. Respiratory medicine.

L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.

J. Manola, D. Cella, M. Fisch, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety Of Fedratinib (SAR302503/TG101348) In Patients With Intermediate- Or High-Risk Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Or Post-Essential Thrombocythemia (ET) MF Previously Treated With Ruxolitinib: Interim Results From a Phase II Study (JAKARTA-2)

Weiliang Shi, K. Döhner, J. Cortes, 2013 .